Andera Partners reported 8 holdings worth US$206M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Jul 22, 2026
Andera Partners reported 8 holdings worth US$206M as of Jun 30, 2026. Largest: Kestra Medical Technologies, Ltd., Mineralys Therapeutics, Inc. and Avalyn Pharma Inc. Filed Jul 22, 2026 (Form 13F).
- Holdings
- 8
- Value as reported
- US$206M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Kestra Medical Technologies, Ltd. | 2.73M | US$69.4M | 33.6% |
| Mineralys Therapeutics, Inc. | 1.59M | US$42.9M | 20.8% |
| Avalyn Pharma Inc. | 930K | US$30.6M | 14.8% |
| Evommune, Inc. | 1.39M | US$18.5M | 9.0% |
| Inventiva Sa | 3.63M | US$13.7M | 6.7% |
| Abivax Sa | 78,125 | US$10.4M | 5.0% |